Hera Biotech
San Antonio, US · Founded 2020 · Delaware corporation · 6 known investors
Find your way into Hera Biotech
45 people in our graph share verified history with the Hera Biotech team — schools, employers, funds. One of them is your warm intro.
Tiby Erdelyunlockedknows Somer Baburek · together at The University of Texas at San Antonio (overlapped)
×6knows the team · via The University of Texas at San Antonio
×4knows the team · via Targeted Technology Funds
knows the team · via LSU Shreveport
Hera Biotech develops diagnostics for women's health, aiming to detect conditions that legacy tools miss. Its platform is presented as AI-enabled and science-based, intended for clinical care settings.
Founders & leadership
Hera Biotech was founded in 2020 by Somer Baburek.
SB
Somer BaburekinCo-Founder, CEO, PresidentSomer Baburek is an executive officer and director at Hera Biotech, which develops AI-enabled diagnostics for women's health conditions.
Board
PC
WS
Wendy SmithBoard director
NW
Neal Walsdorf, Jr.Board director
Investors · 6
Also in the syndicate · 3
Althea Group VenturesKendra Scott Women’s Entrepreneurial Leadership InstituteStella Angels
Funding
SEC filings, press & company announcements$3.8M disclosed across 4 of 5 rounds · 2020–2025
- $1.9Mseed financing roundAug 2022 · 2 sources
Althea Group Ventures, Coyote Ventures, Kendra Scott Women’s Entrepreneurial Leadership Institute, Stella Angels
Source ↗
▶$796.3KraisedSep 2025 · 8 investors · BiotechnologyRule 506(b)
▶$796.3KraisedSep 2025 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Somer BaburekExecutive Officer, Director
- Paul CastellaDirector
- Wendy SmithDirector
- Neal Walsdorf, Jr.Director
- Offering amount
- $5M
- Amount sold
- $796.3K
- First sale
- Apr 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6MofferedAug 2024 · BiotechnologyRule 506(b)
▶$6MofferedAug 2024 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Paul CastellaDirector
- Wendy SmithDirector
- Somer BaburekExecutive Officer, Director
- Neal Walsdorf, Jr.Director
- Offering amount
- $6M
- First sale
- Aug 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$260KraisedMay 2023 · 4 investors · BiotechnologyRule 506(b)
▶$260KraisedMay 2023 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Wendy SmithDirector
- Neal Walsdorf, Jr.Director
- Paul CastellaExecutive Officer, Director
- Somer BaburekExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $260K
- First sale
- May 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$853.5KraisedFeb 2022 · 19 investors · BiotechnologyRule 506(b)
▶$853.5KraisedFeb 2022 · 19 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Paul CastellaExecutive Officer, Director
- Neal Walsdorf, Jr.Director
- Wendy SmithDirector
- Somer BaburekExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $853.5K
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlap
Hera Health Solutions17 shared keywordsHera Health Solutions is a biotechnology company that develops a proprietary nanotechnology platform to reformulate existing pharmaceutical compounds into more effective and longer-acting therapies. The platform enables rapid optimization of drugs with improved release profiles, reduced toxicity, and scalable manufacturing.
Hera Women's Health14 shared keywordsHera Women's Health partners with independent women's health providers to deliver clinical and operational support, modernizing practice operations while preserving physician independence and community relationships. The organization aims to improve healthcare delivery for women by removing administrative barriers and enabling providers to focus on patient care.
Hera11 shared keywordsHello Hera provides senior care coordination services delivered by human "Heroes" supported by AI, handling insurance, appointments, medication management, and other non-clinical care tasks for families with aging parents. The service is covered by Medicare, targeting families managing complex senior healthcare needs.
Hera BioLabs8 shared keywordsHera BioLabs provides gene editing technologies and cell line development services for drug discovery researchers. The company offers custom cell line platforms, animal models, and bioprocessing solutions using transposase technology and proprietary tools like the SRG Rat platform and CleanCut GS CHO system.
Companies competing with Hera Biotech for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Hera Biotech do?
- Hera Biotech develops diagnostics for women's health, aiming to detect conditions that legacy tools miss. Its platform is presented as AI-enabled and science-based, intended for clinical care settings.
- Who founded Hera Biotech?
- Hera Biotech was founded by Somer Baburek in 2020.
- Who are Hera Biotech's investors?
- Hera Biotech's investors include Coyote Ventures, Portfolia, VentureDNA.
- How much funding has Hera Biotech raised?
- Hera Biotech has disclosed $3.8M raised across 4 of its 5 known rounds.
- Where is Hera Biotech headquartered?
- Hera Biotech is headquartered in San Antonio, US.